Your browser doesn't support javascript.
loading
Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors.
Ribeiro, Carlos J A; Kankanala, Jayakanth; Xie, Jiashu; Williams, Jessica; Aihara, Hideki; Wang, Zhengqiang.
Afiliação
  • Ribeiro CJA; Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Kankanala J; Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Xie J; Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Williams J; Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Aihara H; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, United States.
  • Wang Z; Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: wangx472@umn.edu.
Bioorg Med Chem Lett ; 29(2): 257-261, 2019 01 15.
Article em En | MEDLINE | ID: mdl-30522956

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Fatores de Transcrição / Triazóis / Proteínas Nucleares / Inibidores Enzimáticos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Fatores de Transcrição / Triazóis / Proteínas Nucleares / Inibidores Enzimáticos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article